Company name

ReproCELL Incorporated

Established

February 26th, 2003

Location

• Head Office/Laboratory
• KDX Shin-Yokohama 381 Bldg. 9F
• 3-8-11,Shin-Yokohama,
• Kohoku-ku, Yokohama
• Kanagawa 222-0033,
• Japan

Board of Directors

• CEO: Chikafumi Yokoyama Ph.D.
• CTO: Yasuyuki Asai, Ph.D.
• Director: Yoshiyuki Yamakawa (HIBIKI Partners Co.Ltd., CEO)
• Auditor: Yukari Sakai

Business Areas

• Research reagents for human ES/iPS culture
• Human iPSC-derived cardiomyocytes (launched in April 2009, World’s first commercial product)
• Human iPSC-derived neurons (launched in October 2010, World’s first commercial product)
• Human iPSC-derived hepatocytes
• Primary cells for diabetes research
• Disease model cell generation using human iPS cell technologies

Related research organizations

• Institute for Integrated Cell-Material Sciences, Kyoto University
• The Institute of Medical Sciences, Tokyo University
• Graduate School of Medicine, Chiba University